02.12.2025 01:25 — 👍 1 🔁 0 💬 0 📌 0
Editorial que acompaña el artículo
02.12.2025 00:31 — 👍 0 🔁 0 💬 0 📌 0
Shorter antibiotic prophylaxis durations (including 0 days) were noninferior to longer durations for all-cause mortality, but not for early rebleed or bacterial infections.
02.12.2025 00:27 — 👍 0 🔁 0 💬 0 📌 0
El momento óptimo de administración, las estrategias de dosificación y la selección de pacientes requieren mayor investigación.
02.12.2025 00:11 — 👍 0 🔁 0 💬 1 📌 0
Los esteroides sistémicos pueden reducir la incidencia de shock secundario en la neumonía grave. En ambas afecciones, los corticosteroides pueden tener poco o ningún efecto sobre las infecciones nosocomiales.
02.12.2025 00:11 — 👍 0 🔁 0 💬 1 📌 0
CONCLUSIÓN: corticosteroides a dosis bajas y corta duración probablemente reduce la mortalidad a corto plazo en neumonía grave y en SDRA (evidencia moderada); mortalidad a largo plazo, evidencia incierta.
02.12.2025 00:11 — 👍 0 🔁 0 💬 1 📌 0
In 2025, sudden US funding cuts and reductions from key donors shocked the global AIDS response.
Today, we're releasing a new report showing how these disruptions unfolded & the resilience of communities and countries protecting progress.
Join live at 2pm CET: webtv.un.org/en/asset/k1x...
25.11.2025 10:22 — 👍 19 🔁 6 💬 0 📌 2
Validate User
Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures url: academic.oup.com/cid/article/...
23.11.2025 10:17 — 👍 0 🔁 0 💬 0 📌 0
Still, at the current price, lenacapavir will remain an
unreachable preventive tool for many individuals at
risk of HIV. As Winnie Byanyima, Executive Director of
UNAIDS, said in an interview, “If this game-changing
medicine remains unaffordable, it will change nothing”
22.11.2025 02:18 — 👍 0 🔁 0 💬 0 📌 0
El autor advierte sobre el “autodiagnóstico”, no tanto por sensibilidad y especificidad de la prueba, si no por la posible pérdida de oportunidad de consejo, educación, derivación a programas de PrEP, vacunaciones … ¿Qué pensáis sobre como se debería gestionar el “autodiagnóstico”?
19.11.2025 01:13 — 👍 0 🔁 0 💬 0 📌 0
🛑 Risk Update – Ethiopia Ethiopia’s risk index has been updated following the confirmation of a Marburg virus disease outbreak,
hashtag#GlobalRiskAtlas hashtag#Marburg hashtag#GlobalHealth hashtag#RiskUpdate hashtag#EpidemiologicalSurveillance globalriskatlas.com/en/%f0%9f%9b...
18.11.2025 22:57 — 👍 0 🔁 1 💬 0 📌 0
😌 Domingo. Fin de la semana epidemiológica.
Los virus también descansan… o eso quisiéramos creer.
Mientras el mundo apaga las luces, los datos siguen llegando.
Cada brote deja una señal, cada alerta una historia.
🛰️ hradar.com
| 🌍 globalriskatlas.com
#HRadar #GlobalRiskAtlas #FundacioniO
09.11.2025 19:22 — 👍 1 🔁 1 💬 0 📌 0
American Association for the Study of Liver Diseases Meeting 2025
Original Article | Nov 9, 2025 | NEJM.org
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
Figure 2A. HDV RNA Responses.
The NEJM identity sits at the bottom.
Tobevibart plus elebsiran and tobevibart alone both lowered HDV RNA and ALT levels. The combination resulted in a high incidence of undetectable HDV RNA and an HBsAg level below 10 IU/ml at week 48. Full SOLSTICE phase 2 trial results: nej.md/4qIXpuM
@aasldnews.bsky.social | #TLM25
09.11.2025 23:05 — 👍 9 🔁 3 💬 0 📌 0
¿Miramos a otro lado?
Are we looking the other way?
10.11.2025 01:13 — 👍 0 🔁 0 💬 0 📌 0
Ensayo pragmático de glucocorticoides para la neumonía adquirida en la comunidad | New England Journal of Medicine www.nejm.org/doi/full/10....
En NAC en entornos con recursos limitados, la terapia adyuvante con glucocorticoides se asoció con un menor riesgo de muerte que el tratamiento estándar
29.10.2025 22:40 — 👍 0 🔁 0 💬 0 📌 0
ID at @washuID obsessed with fungal infections. Section Chief, Transplant ID. #fungus #TxID #IDTwitter Head of @WU_Mycoses. Deputy Editor-OFID. He/Him
🧫ID physician-scientist in the making
🎙️Co-host “Sensible & Resistente” Podcast
📝TAE-SC Education officer ESCMID
Servicio de Enfermedades Infecciosas del Hospital Universitario Ramón y Cajal /
Department of Infectious Diseases, University Hospital Ramón y Cajal
Orthopedic infections doc.
JAMA Internal Medicine is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
🌐 JAMAInternalMed.com
The nonprofit behind the licenses & tools the world uses to share 🌍
Infectious diseases, clinical trials, staphylococcus and streptococcus. Reader and runner. Go Hawks!
Infectious Diseases physician, clinical researcher - clinical trials, SAB, PJI, sepsis, viral hep. CI of SNAP and ROADMAP trials. Runner, Novocastrian, Dad (and thus Dad jokes ++), Chocoholic
#IDSky #SNAPtrial
Grupo #PROA (Programa Optimización Antimicrobianos) / Servicio Enfermedades Infecciosas, Hospital Virgen Macarena, Sevilla.
#AntimicrobialStewardship
#AMSsky #IDsky
Explore antimicrobial stewardship and resistance research from @bsacandjac.bsky.social's fully #OpenAccess journal
#JACAMRNews
Championing medical progress in infection for a healthier tomorrow. ESCMID is committed to advancing the fields of Clinical Microbiology and Infectious Diseases.
Infectiologue, Hôpital Bichat - Claude Bernard, AP-HP
Professeur, Université Paris Cité
Chercheur, IAME, Inserm
Infectiologie transversale/AMS ID physician. Infections en hématologie/in hematology patients. PRI/ICP on the side
M.D., M.Sc. Amateur de SF et de comics, webmaster gilar.org /
www.infectiologie.com . My skeets are my own.
Infectious Diseases doctor (at UCLH) and academic (at UCL). Research focuses on immune responses to TB and leprosy, but I'm also involved in too many other projects I probably shouldn't be...
Healthcare Sustainability × Infectious Diseases | Collaborative for infectious diseases physicians, trainees & pharmacists to integrate environmental sustainability into daily infectious diseases practices | #IDsky #medsky #pedsIDsky
Lead Pharmacist, AMR;
Deputy Chief Scientist;
Honorary Professor of #PharmaceuticalPublicHealth
#ESPAUR, #Antibioticguardian, Mum. #FRPharmS (consultant). #TEDx x2
UkPharmResearch starter pack https://go.bsky.app/L297FYc
Professor of Paediatric Infection, University of Liverpool. Sepsis, antimicrobial stewardship, biomarker-guided trials in infection, paediatric early warning scores, health inequalities. Personal views.
